Divi's Laboratories Osake

Divi's Laboratories EBITDA

EBITDA (Tulos ennen korkoja, veroja ja poistoja) yhtiöstä Divi's Laboratories (DIVISLAB.NS) 6.8.2026 päivämäärällä on 29,72 Mrd. INR. Edellisenä vuonna EBITDA (Tulos ennen korkoja, veroja ja poistoja) oli 22,09 Mrd. INR — muutos 34,54 % (korkeampi).

EBITDA

29,72 Mrd.INR

YoY

34,54%

Viimeksi päivitetty:

EBITDA (Tulos ennen korkoja, veroja ja poistoja) yhtiöstä Divi's Laboratories on 2026 29,72 Mrd. INR. EBITDA (Tulos ennen korkoja, veroja ja poistoja) yhtiöstä Divi's Laboratories oli 2025 22,09 Mrd. INR. Se laskee 34,54% korkeampi edelliseen vuoteen verrattuna.
Access this data via the Eulerpool API

Divi's Laboratories Osakeanalyysi

Mitä Divi's Laboratories tekee? Divi's Laboratories Ltd. is a pharmaceutical company based in Hyderabad, India. It was founded in 1990 and has become one of the leading manufacturers of active ingredients and formulations for the pharmaceutical industry in recent years. The company was founded by Dr. Murali Divi, who built the company on principles of quality, technology, and innovation. Divi's Laboratories now employs approximately 13,000 employees and operates production facilities in India and the USA. The company operates in various sectors, including generics, custom synthesis, research and development, and nutraceuticals. Its products are used worldwide and are approved in over 95 countries. Divi's Laboratories follows a vertically integrated supply chain model, producing high-quality active ingredients and developing its own formulations for the pharmaceutical industry. The company always relies on innovative technologies and continuous improvement of product quality. Its product range includes a wide range of active ingredients for various therapeutic areas, such as antibiotics, antidepressants, antihypertensives, antidiabetics, static lipid-lowering agents, and antipsychotics. Divi's Laboratories has state-of-the-art production facilities, strict quality controls, and advanced analytical facilities for all pharmaceutical ingredients. In addition to its active ingredients, the company is also known for its custom synthesis services, which involve the production of customer-specific active ingredients for the pharmaceutical industry. Divi's Laboratories offers a tailored service that meets the specific requirements of customers, ranging from the development of new active ingredients and formulations to the production of small or medium quantities of active ingredients. In the area of research and development, Divi's Laboratories works closely with academic institutions and other pharmaceutical companies to leverage the latest scientific knowledge and develop innovative products. The company invests a significant sum in research and development annually. In addition to active ingredients and custom synthesis services, Divi's Laboratories also offers a range of nutraceuticals. These products, such as vitamins, minerals, and other dietary supplements, are used to support a healthy lifestyle. In summary, Divi's Laboratories is an India-based pharmaceutical company specializing in the manufacture of active ingredients and formulations for the pharmaceutical industry. The company operates to the highest quality standards and relies on innovative technologies and sustainable product development. The wide product range and custom synthesis services offer customers a tailored solution for their needs. Divi's Laboratories is a leading provider of active ingredients and has made a name for itself in the pharmaceutical and nutraceutical industry due to its high quality and productivity. Divi's Laboratories on yksi Eurpooliin suosituimmista yhtiöistä.

Usein kysytyt kysymykset Divi's Laboratories osakkeesta

Yhtiön Divi's Laboratories EBITDA (Tulos ennen korkoja, veroja ja poistoja) on 29,72 Mrd. INR vuonna 2026.

EBITDA (Tulos ennen korkoja, veroja ja poistoja) yhtiöstä Divi's Laboratories muuttui arvosta 22,09 Mrd. INR arvoon 29,72 Mrd. INR, mikä edustaa 34,54 % muutosta. Arvo on korkeampi kuin edellisenä vuonna.

Eurpoolissa voit löytää EBITDA (Tulos ennen korkoja, veroja ja poistoja) Divi's Laboratories:n täydellisen historiallisen kehityksen vuodesta 2006 lähtien – vuotuisten arvojen, kaavioiden ja yksityiskohtaisen analyysin kanssa.

EBITDA mittaa operatiivista suorituskykyä ennen rahoitusrakenteen, veroympäristön ja muiden kuin käteispoisto-osuuksien vaikutusta.

EBITDA = EBIT + Poistot

EBITDA (Tulos ennen korkoja, veroja ja poistoja):n INR on sijoittajille tärkeä tekijä. Muutokset tässä tunnusluvussa voivat signaloida parantuvia tai heikentyneitä perustekijöitä, mikä vaikuttaa suoraan osakekurssiin. Eulerpoolissa voit seurata EBITDA (Tulos ennen korkoja, veroja ja poistoja):n Divi's Laboratories historiallisesti ja reaaliajassa.

Access this data via the Eulerpool API

Tuloslaskelma — Divi's Laboratories

Kaikki tunnusluvut — Divi's Laboratories